- Home
- IKT vs ASM Comparison
IKT vs ASM Comparison
Compare IKT & ASM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- ASM
- Stock Information
- Founded
- IKT 2008
- ASM 1968
- Country
- IKT United States
- ASM Canada
- Employees
- IKT N/A
- ASM N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- ASM Metal Mining
- Sector
- IKT Health Care
- ASM Basic Materials
- Exchange
- IKT Nasdaq
- ASM Nasdaq
- Market Cap
- IKT 159.2M
- ASM 148.8M
- IPO Year
- IKT 2020
- ASM N/A
- Fundamental
- Price
- IKT $2.96
- ASM $1.19
- Analyst Decision
- IKT Strong Buy
- ASM Strong Buy
- Analyst Count
- IKT 1
- ASM 2
- Target Price
- IKT $5.00
- ASM $1.55
- AVG Volume (30 Days)
- IKT 318.4K
- ASM 2.0M
- Earning Date
- IKT 11-12-2024
- ASM 11-12-2024
- Dividend Yield
- IKT N/A
- ASM N/A
- EPS Growth
- IKT N/A
- ASM N/A
- EPS
- IKT N/A
- ASM 0.01
- Revenue
- IKT $79,570.00
- ASM $52,026,000.00
- Revenue This Year
- IKT N/A
- ASM $42.45
- Revenue Next Year
- IKT N/A
- ASM $28.53
- P/E Ratio
- IKT N/A
- ASM $100.39
- Revenue Growth
- IKT N/A
- ASM 21.53
- 52 Week Low
- IKT $0.80
- ASM $0.42
- 52 Week High
- IKT $3.82
- ASM $1.56
- Technical
- Relative Strength Index (RSI)
- IKT 76.96
- ASM 46.55
- Support Level
- IKT $2.56
- ASM $1.09
- Resistance Level
- IKT $2.75
- ASM $1.25
- Average True Range (ATR)
- IKT 0.27
- ASM 0.08
- MACD
- IKT 0.03
- ASM -0.03
- Stochastic Oscillator
- IKT 96.43
- ASM 29.81
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About ASM Avino Silver & Gold Mines Ltd. (Canada)
Avino Silver & Gold Mines Ltd is a mineral resource company. It is engaged in the exploration, extraction, and processing of silver, gold, and copper and the acquisition, exploration, and advancement of mineral properties. The company generates majority of its revenues through the sale of Copper produced from its mines. Its project portfolio includes Avino; San Gonzalo; Oxide Tailings; Bralorne Gold and others.